Sisi Deng
Chongqing Municipal Health Commission Key Laboratory Of Immunological Skin Diseases
Chongqing, China
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Real-world outcomes of 24-week abrocitinib tapering in moderate-to-severe atopic dermatitis: Feasibility and regimen comparison.
Journal: Journal of the American Academy of Dermatology
Published: May 19, 2026
Efficacy and Safety of Tofacitinib in the Treatment of Refractory Chronic Spontaneous Urticaria: A Real-World Study.
Journal: Journal of the American Academy of Dermatology
Published: May 17, 2026
Predictors of Super/Poor Omalizumab Response in Chinese Refractory Chronic Spontaneous Urticaria.
Journal: Dermatology (Basel, Switzerland)
Published: November 02, 2025
Tofacitinib for the Treatment of Refractory Severe Acute Urticaria: A Retrospective Case Series.
Journal: American journal of therapeutics
Published: September 18, 2025
Digital Health Interventions in Pediatric Perioperative Care: A Network Meta-Analysis.
Journal: JAMA pediatrics
Published: September 15, 2025
The effect of enhanced recovery after surgery in laparoscopic sacrocolpopexy: a randomized controlled trial.
Journal: International journal of surgery (London, England)
Published: June 19, 2025
Characterizing Atopic Dermatitis and Abrocitinib Early Response Through Tape-Stripped and Serum Biomarkers.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: June 13, 2025
Digital health interventions for perioperative patient-reported outcomes: a network meta-analysis.
Journal: NPJ digital medicine
Published: June 02, 2025
Both Extrinsic and Intrinsic Atopy in Chronic Spontaneous Urticaria Patients Indicate a Favorable Response to Omalizumab Treatment.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: May 21, 2025
Peripheral Blood ILC2s Levels Are Associated with Autoimmunity and Atopy in Chronic Spontaneous Urticaria: A Preliminary Study.
Journal: International archives of allergy and immunology
Published: May 05, 2025
Tolerability and efficacy of unorthodox dosing regimens of tofacitinib and baricitinib in pediatric patients with moderate to severe alopecia areata.
Journal: Journal of the American Academy of Dermatology
Published: April 05, 2025
Abrocitinib Treatment Modes: Impact on Prognosis and Relapse Rates in Atopic Dermatitis.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: April 02, 2025
Last Updated: 09/26/2026